Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A02BC02	PANTOPRAZOL SALA	G	Pantoprazole (sodium) - 40mg	40mg	Injectable powder for solution	503,941 L.L
A08AB01	ELIZA 120	G	Orlistat - 120mg	120mg	Capsule	1,711,159 L.L
B05CX01	GLUCOSE INJ.	G	Glucose - 10g/20ml	50%	Injectable solution	5,038,066 L.L
C09CA06	ANDESART 8	G	Candesartan cilexetil - 8mg	8mg	Tablet	498,566 L.L
C10AA07	SINLIP	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet, film coated	563,070 L.L
D10AD51	MEDCLINIDERM-T	G	Tretinoin - 0.05%, Clindamycin (phosphate) - 1%		Gel	890,776 L.L
G04BE09	LEVIDOR	G	Vardenafil (HCl) - 20mg	20mg	Tablet	401,809 L.L
J01DC02	CEFUMAX	G	Cefuroxime (sodium) - 750mg	750mg	Injectable dry powder	159,917 L.L
J01MA12	MATADOR	G	Levofloxacin - 500mg	500mg	Tablet, film coated	787,492 L.L
L04AA29	TRIJAN	G	Tofacitinib - 5mg	5mg	Tablet, film coated	54,863,315 L.L
M01AH01	CELECOXIB BIOGARAN	G	Celecoxib - 100mg	100mg	Capsule	318,491 L.L
N02BE01	PAINOL	G	Paracetamol - 500mg	500mg	Tablet	95,989 L.L
N04BC05	PRAMIPEXOLE BIOGARAN	G	Pramipexole (dihydrochloride monohydrate) - 0.18mg	0.18mg	Tablet	440,780 L.L
N06AB10	PRAMACYT 5	G	Escitalopram (oxalate) - 5mg	5mg	Tablet, film coated	895,895 L.L
R03AK06	SEROFLO 250	G	Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 250mcg/inhalation		Inhalation suspension	1,580,359 L.L
A02BC03	JOSWE LANZOTEC 30	G	Lansoprazole - 30mg	30mg	Capsule	271,456 L.L
A08AB01	LESSFAT	G	Orlistat - 120mg	120mg	Capsule	391,634 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 33g/100ml	33g/100ml	Injectable solution	287,295 L.L
C09CA06	ARKANDA 8	G	Candesartan cilexetil - 8mg	8mg	Tablet	639,925 L.L
C10AA07	SUPERSTAT	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet, coated	517,379 L.L
G04BE09	VERDA	G	Vardenafil (HCl) - 10mg	10mg	Tablet, orally disintegrating	1,023,880 L.L
J01DC02	CEFUROXIME – PANPHARMAPOUDRE POUR SOLUTION INJ. IM/IV	G	Cefuroxime (sodium) - 750mg	750mg	Injectable dry powder	3,922,676 L.L
J01MA12	OXALEV	G	Levofloxacin - 500mg	500mg	Tablet, film coated	791,523 L.L
L01EX01	SOVIDEX	G	Sunitinib maleate - 25mg	25mg	Capsule	64,804,314 L.L
N02BE01	PARACETAMOL	G	Paracetamol - 500mg	500mg	Tablet	1,873,700 L.L
N06AB10	PRYLEX 5	G	Escitalopram (oxalate) - 5mg	5mg	Tablet, film coated	895,895 L.L
R03AK06	SEROFLO-S 250	G	Salmeterol (xinafoate) - 25mcg/inhalation, Fluticasone propionate - 250mcg/inhalation		Inhalation suspension	1,725,494 L.L
A02BC03	JOSWE LANZOTEC 30	G	Lansoprazole - 30mg	30mg	Capsule	514,692 L.L
A08AB01	ONLEFIT	G	Orlistat - 120mg	120mg	Capsule	1,537,356 L.L
A11CC05	ALTO D 10.000	G	Vitamin D3 - 10,000IU	10,000IU	Capsule	895,895 L.L